Yang Chao-Yie
Department of Internal Medicine, Hematology and Oncology Division, University of Michigan, Ann Arbor, Michigan, United States of America.
PLoS One. 2015 Feb 23;10(2):e0118671. doi: 10.1371/journal.pone.0118671. eCollection 2015.
The interleukin-1 receptor (IL-1R) is the founding member of the interleukin 1 receptor family which activates innate immune response by its binding to cytokines. Reports showed dysregulation of cytokine production leads to aberrant immune cells activation which contributes to auto-inflammatory disorders and diseases. Current therapeutic strategies focus on utilizing antibodies or chimeric cytokine biologics. The large protein-protein interaction interface between cytokine receptor and cytokine poses a challenge in identifying binding sites for small molecule inhibitor development. Based on the significant conformational change of IL-1R type 1 (IL-1R1) ectodomain upon binding to different ligands observed in crystal structures, we hypothesized that transient small molecule binding sites may exist when IL-1R1 undergoes conformational transition and thus suitable for inhibitor development. Here, we employed accelerated molecular dynamics (MD) simulation to efficiently sample conformational space of IL-1R1 ectodomain. Representative IL-1R1 ectodomain conformations determined from the hierarchy cluster analysis were analyzed by the SiteMap program which leads to identify small molecule binding sites at the protein-protein interaction interface and allosteric modulator locations. The cosolvent mapping analysis using phenol as the probe molecule further confirms the allosteric modulator site as a binding hotspot. Eight highest ranked fragment molecules identified from in silico screening at the modulator site were evaluated by MD simulations. Four of them restricted the IL-1R1 dynamical motion to inactive conformational space. The strategy from this study, subject to in vitro experimental validation, can be useful to identify small molecule compounds targeting the allosteric modulator sites of IL-1R and prevent IL-1R from binding to cytokine by trapping IL-1R in inactive conformations.
白细胞介素-1受体(IL-1R)是白细胞介素1受体家族的创始成员,它通过与细胞因子结合来激活先天免疫反应。报告显示,细胞因子产生的失调会导致免疫细胞异常激活,进而引发自身炎症性疾病。目前的治疗策略集中在使用抗体或嵌合细胞因子生物制剂。细胞因子受体与细胞因子之间巨大的蛋白质-蛋白质相互作用界面,给小分子抑制剂开发中结合位点的识别带来了挑战。基于在晶体结构中观察到的1型IL-1R(IL-1R1)胞外域与不同配体结合时的显著构象变化,我们推测当IL-1R1发生构象转变时可能存在瞬时小分子结合位点,因此适合用于抑制剂开发。在这里,我们采用加速分子动力学(MD)模拟来高效采样IL-1R1胞外域的构象空间。通过层次聚类分析确定的代表性IL-1R1胞外域构象,由SiteMap程序进行分析,从而在蛋白质-蛋白质相互作用界面和变构调节剂位置识别小分子结合位点。使用苯酚作为探针分子的共溶剂图谱分析进一步证实了变构调节剂位点是一个结合热点。通过MD模拟评估了从计算机筛选在调节剂位点鉴定出的八个排名最高的片段分子。其中四个将IL-1R1的动态运动限制在非活性构象空间。本研究的策略有待体外实验验证,可能有助于识别靶向IL-1R变构调节剂位点的小分子化合物,并通过将IL-1R捕获在非活性构象中来阻止IL-1R与细胞因子结合。